Aftercare of Childhood Cancer Survivors in Switzerland

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age16+
SponsorKantonsspital Aarau

About this trial

The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

5-year survivor of childhood cancer

Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)

Age at diagnosis <18 years

Age at study ≥16 years

Disqualifiers

Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)

<5 years after therapy of a relapse or palliative situation

Severe cognitive impairment, which makes it impossible to complete the questionnaire independently

Insufficient knowledge of the German language

Trial population

The study population consists of childhood cancer survivors, who were diagnosed in three Swiss pediatric oncology centers at age \<18 years and are ≥5-year from diagnosis and age ≥16 years at study inclusion. Additionally, survivors are at study start in follow-up care at one of the three pediatric oncology centers (group before transition) or have been transitioned to adult care not before 2014 (group after transition)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Transition model

    Other intervention

    Transition of follow-up care of childhood cancer survivors to adult care

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Cancer Worry as part of transition readiness

Assessment via validated "Cancer Worry Scale"

Time frame
Change from baseline to 3 month and 15 month
2

Self-management as part of transition readiness

Assessment via validated "Self-Management Skill Scale"

Time frame
Change from baseline to 3 month and 15 month
3

Evaluation of needs for ongoing care as part of transition readiness

Assessment via validated "Scale for ongoing Care"

Time frame
Change from baseline to 3 month and 15 month
4

Evaluation of expectation for transition as part of transition readiness

Assessment via validated "Expectation Scale"

Time frame
Change from baseline to 3 month and 15 month

Secondary outcomes

1

Survivors' cancer specific knowledge

Assessment via questionnaire

Time frame
Change from baseline to 3 month and 15 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kantonsspital Aarau

Lead sponsor

University Children's Hospital Basel

Collaborator

Luzerner Kantonsspital

Collaborator